High-Risk IV Medications in Special Patient Populations

Valutazione media 0
( su 0 valutazioni fornite da GoodReads )
9780857296054: High-Risk IV Medications in Special Patient Populations

Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Book Description:

From the reviews:

“This book reviews the use of intravenous medications in patient populations with special considerations, discussing the dosing guidelines, safety concerns, and monitoring parameters. … It is intended for clinicians treating critically ill patients with high-risk intravenous medications. This is a good reference for doctors, nurses, pharmacists, and students in these disciplines to use to become well versed in the safe use of dangerous medications. … This is an excellent book that provides clear, concise information in a very usable format.”­­­ (Judith Klevan, Doody’s Review Service, November, 2011)

Dalla quarta di copertina:

Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill – requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal circulation devices, advanced age, pharmacogenetic alterations, hemodynamic instability, or therapeutic hypothermia – are particularly challenging. A contributing factor to this is the use of high-risk medications with many administered intravenously (IV). Hypervigilant monitoring of high-risk medications is still essential to prevent patient harm, especially in populations that have dosing challenges, hence, regulatory bodies internationally require active institutional surveillance of high-risk medications. These dosing challenges are a great safety concern, since there is considerable risk of unwanted adverse drug events from overdosing or therapeutic inefficacy from underdosing.
High-Risk IV Medications in Special Patient Populations reviews high-risk IV medication dosage considerations for special patient populations and discusses the safety concerns of these medications to aid the clinician in cautious monitoring.  The authors provide clinicians with tools to minimize adverse drug events with IV high-risk medications, while maximizing the beneficial clinical effects of these drugs, thus making this book essential reading for all involved with the care of critically ill patients. 

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

I migliori risultati di ricerca su AbeBooks

1.

Editore: Springer London Ltd, United Kingdom (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Rilegato Quantità: 10
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer London Ltd, United Kingdom, 2011. Hardback. Condizione libro: New. 2011. 252 x 164 mm. Language: English . Brand New Book. Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions. Codice libro della libreria SPR9780857296054

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 138,24
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

2.

Editore: Springer London Ltd, United Kingdom (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Rilegato Quantità: 10
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer London Ltd, United Kingdom, 2011. Hardback. Condizione libro: New. 2011. 252 x 164 mm. Language: English . Brand New Book. Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions. Codice libro della libreria SPR9780857296054

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 139,39
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

3.

Sandra Kane-Gill
Editore: Springer London Ltd (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Quantità: > 20
Print on Demand
Da
PBShop
(Secaucus, NJ, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer London Ltd, 2011. HRD. Condizione libro: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice libro della libreria I1-9780857296054

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 137,69
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,74
In U.S.A.
Destinazione, tempi e costi

4.

Sandra Kane-Gill (Editor), Joseph Dasta (Editor)
Editore: Springer (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Rilegato Quantità: 1
Print on Demand
Da
Ergodebooks
(RICHMOND, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer, 2011. Hardcover. Condizione libro: New. 2011. This item is printed on demand. Codice libro della libreria DADAX0857296051

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 137,82
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,74
In U.S.A.
Destinazione, tempi e costi

5.

Sandra Kane-Gill
Editore: Springer London Ltd (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Quantità: > 20
Print on Demand
Da
Books2Anywhere
(Fairford, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer London Ltd, 2011. HRD. Condizione libro: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice libro della libreria I1-9780857296054

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 133,85
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 10,63
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

6.

SANDRA KANE-GILL
Editore: Springer (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Rilegato Quantità: 1
Da
Herb Tandree Philosophy Books
(Stroud, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, 2011. Hardback. Condizione libro: NEW. 9780857296054 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Codice libro della libreria HTANDREE0286427

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 139,79
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 9,45
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

7.

Editore: Springer (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Rilegato Quantità: 1
Da
Irish Booksellers
(Rumford, ME, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer, 2011. Hardcover. Condizione libro: New. book. Codice libro della libreria 0857296051

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 157,13
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

8.

Sandra Kane-Gill
Editore: Springer-Verlag Gmbh Jul 2011 (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Quantità: 1
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Jul 2011, 2011. Buch. Condizione libro: Neu. 210x148x18 mm. Neuware - Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal circulation devices, advanced age, pharmacogenetic alterations, hemodynamic instability, or therapeutic hypothermia are particularly challenging. A contributing factor to this is the use of high-risk medications with many administered intravenously (IV). Hypervigilant monitoring of high-risk medications is still essential to prevent patient harm, especially in populations that have dosing challenges, hence, regulatory bodies internationally require active institutional surveillance of high-risk medications. These dosing challenges are a great safety concern, since there is considerable risk of unwanted adverse drug events from overdosing or therapeutic inefficacy from underdosing. High-Risk IV Medications in Special Patient Populations reviews high-risk IV medication dosage considerations for special patient populations and discusses the safety concerns of these medications to aid the clinician in cautious monitoring. The authors provide clinicians with tools to minimize adverse drug events with IV high-risk medications, while maximizing the beneficial clinical effects of these drugs, thus making this book essential reading for all involved with the care of critically ill patients. 160 pp. Englisch. Codice libro della libreria 9780857296054

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 149,79
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 12,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi

9.

Kane-gill, S. (Editor)
Editore: Springer Verlag (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Rilegato Quantità: 2
Da
Revaluation Books
(Exeter, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer Verlag, 2011. Hardcover. Condizione libro: Brand New. 1st edition. 260 pages. 9.75x6.50x0.75 inches. In Stock. Codice libro della libreria z-0857296051

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 157,39
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 7,08
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

10.

Editore: Springer (2011)
ISBN 10: 0857296051 ISBN 13: 9780857296054
Nuovi Rilegato Quantità: 1
Da
English-Book-Service Mannheim
(Mannheim, Germania)
Valutazione libreria
[?]

Descrizione libro Springer, 2011. Condizione libro: New. Codice libro della libreria L9780857296054

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 160,49
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Vedi altre copie di questo libro

Vedi tutti i risultati per questo libro